Sandoz Group (OTCMKTS:SDZNY) Trading Up 1.3% – Here’s What Happened

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNYGet Free Report)’s share price was up 1.3% during trading on Thursday . The company traded as high as $53.89 and last traded at $53.68. Approximately 11,915 shares changed hands during trading, a decline of 62% from the average daily volume of 31,276 shares. The stock had previously closed at $53.01.

Analysts Set New Price Targets

Separately, Royal Bank Of Canada upgraded Sandoz Group from a “hold” rating to a “moderate buy” rating in a report on Friday, May 2nd.

View Our Latest Stock Analysis on SDZNY

Sandoz Group Stock Up 1.3%

The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.79 and a current ratio of 1.24. The company’s 50-day moving average is $47.85 and its 200-day moving average is $44.89.

About Sandoz Group

(Get Free Report)

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.

See Also

Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.